HIGHLIGHTS
- who: Zhichao Tian from the All the STS patients in this retrospective study received nab-paclitaxel/ gemcitabine combination chemotherapy between January , and February This study was approved by the Ethics Committee of The Affiliated Cancer Hospital of Zhengzhou University. All patients provided written informed consent for data collection and research purposes. The inclusion criteria were as follows:, ) histologically proven STS have published the research work: Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma, in the Journal: (JOURNAL)
- what: The authors retrospectively investigate patient outcomes and study the safety and effectiveness of nab . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.